Without medicines made from blood plasma, people with certain chronic illnesses or serious injuries cannot survive. They are

relies on healthy people donating plasma. The International Plasma Donation Week aims to raise global awareness of the

enormous importance of plasma donation

sharpen and improve understanding of life-saving therapies with plasma preparations. The “International Plasma Donation Week” will take place from October 3rd to 7th this year. The Plasma Protein Therapeutics Association Germany e. V. (PPTA) is taking this week as an opportunity to draw attention to the challenges that patients who rely on plasma preparations are currently facing.

This year's International Plasma Donation Week comes at a significant time for Europe, with a number of political and legislative processes coming up, including the EU Medicines Strategy, the Regulation on Substances of Human Origin and Medicines Legislation, said Maarten Van Baelen, Executive Director PPTA Europe. “It is crucial that we take advantage of all these opportunities if we want to increase plasma donation in Europe to reduce our dependence on the US and thus ensure that patients in Europe can receive reliable supplies of plasma products,” he added .
Plasma – the yellowish, liquid part of blood – contains proteins that are necessary for important functions in the human body, such as: B. Antibodies to fight disease and clotting factors to regulate bleeding. Without enough of these proteins in the blood, the body cannot perform many vital functions, which can lead to a number of chronic and life-threatening diseases.
Plasma donation requires a high level of commitment from donors as it can take more than an hour per donation, and plasma donation can be done more frequently than blood donation. The basis for a secure supply of plasma preparations are many healthy donors who donate plasma regularly.

About the PPTA

The Plasma Protein Therapeutics Association (PPTA - www.pptaglobal.org) is a global industry association with branches in Brussels and Berlin (www.pptadeutschland.org) and represents the interests of private manufacturers of plasmatic drugs and their recombinant analogues. It represents five member companies and over 80 private plasma donation centers in Germany. More than 80 percent of the world's plasma preparations are manufactured by PPTA member companies.